Cook, Stuart A. http://orcid.org/0000-0001-6628-194X
Article History
Received: 20 December 2022
Accepted: 21 December 2022
First Online: 11 January 2023
Declarations
:
: S.A.C. is a co-inventor of a number of patents relating to IL11 biology and inhibitors of the IL11 signalling pathway to treat a range of human diseases and to modify regenerative processes. S.A.C. is a co-founder and shareholder of Enleofen Bio PTE LTD, a company that made anti-IL11 therapeutics, which was acquired by Boehringer Ingelheim.